Literature DB >> 3750324

Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster.

H Yamauchi, K Takahashi, Y Yamamura.   

Abstract

This study deals with the metabolism of gallium arsenide (GaAs). GaAs was shown to be soluble in various media. Since this compound could dissolve in aqueous solvents, in vivo dissolution was investigated. Hamsters were used to study the dissolution and subsequent pharmacokinetics of any liberated arsenic species. The fecal and urinary excretion data following oral and intraperitoneal administration showed that GaAs, when administered orally, is mostly excreted in the feces but poorly in the urine, and that the compound, when administered intraperitoneally, is poorly excreted in both the feces and urine. Analysis of tissues for arsenic levels yielded concentrations in the ppb range, which further verified this fact. Most interesting was the fact that dimethylarsinic acid (DMAA) and methylarsonic acid (MAA) along with inorganic arsenic were found in the urine and tissues. GaAs was shown to dissolve in vivo and the released arsenic species were metabolized as other inorganic arsenics were found in the urine and tissues. GaAs was shown to dissolve in vivo and the released arsenic species were metabolized as other inorganic arsenic containing compounds. The low solubility and poor oral absorption may make this compound less toxic than other inorganic arsenic compounds.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3750324     DOI: 10.1016/0300-483x(86)90056-9

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  2 in total

1.  Interaction effects of lead on bioavailability and pharmacokinetics of arsenic in the rat.

Authors:  Violet Diacomanolis; Barry N Noller; Jack C Ng
Journal:  Environ Geochem Health       Date:  2013-06-01       Impact factor: 4.609

2.  Environmental and workplace contamination in the semiconductor industry: implications for future health of the workforce and community.

Authors:  P Edelman
Journal:  Environ Health Perspect       Date:  1990-06       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.